Q1 2022 OpGen Inc Earnings Call Transcript
Welcome to the OpenGen (sic) [OpGen] First Quarter 2022 Earnings Call and Business Update. Today, OpenGen management will provide an update on the company's current business and outlook for the future. Following OpGen's remarks -- prepared remarks, there will be a live Q&A session. As a reminder, this conference call is being recorded today, May 12, 2022 (Operator Instructions)
At this time, we will turn the call over to Alyssa Factor, OpGen's IR representative, to provide the opening statement. Please proceed.
Good afternoon, everyone, and thank you, operator, for the introduction. Before we begin, I would like to note that any comments made by management during this conference call may contain forward-looking statements regarding the operations and future results of OpGen, including its subsidiaries, Curetis and Ares Genetics.
I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K and Form 10-Q for the first
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |